O
AGN
OrbiMed’s Allergan plc AGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-957,000
| Closed | -$128M | – | 142 |
|
|
2018
Q4 | $128M | Sell |
957,000
-193,405
| -17% | -$25.9M | 2.37% | 10 |
|
|
2018
Q3 | $219M | Sell |
1,150,405
-135,800
| -11% | -$25.9M | 2.64% | 9 |
|
|
2018
Q2 | $214M | Buy |
1,286,205
+592,600
| +85% | +$98.8M | 2.56% | 8 |
|
|
2018
Q1 | $117M | Buy |
693,605
+406,315
| +141% | +$68.4M | 1.45% | 20 |
|
|
2017
Q4 | $47M | Sell |
287,290
-86,300
| -23% | -$14.1M | 0.59% | 48 |
|
|
2017
Q3 | $76.6M | Hold |
373,590
| – | – | 0.73% | 39 |
|
|
2017
Q2 | $90.8M | Sell |
373,590
-103,800
| -22% | -$25.2M | 0.95% | 33 |
|
|
2017
Q1 | $114M | Sell |
477,390
-292,300
| -38% | -$69.8M | 1.29% | 25 |
|
|
2016
Q4 | $162M | Sell |
769,690
-9,000
| -1% | -$1.89M | 2.06% | 15 |
|
|
2016
Q3 | $179M | Sell |
778,690
-565,925
| -42% | -$130M | 2.04% | 11 |
|
|
2016
Q2 | $311M | Sell |
1,344,615
-228,100
| -15% | -$52.7M | 3.24% | 8 |
|
|
2016
Q1 | $422M | Buy |
1,572,715
+148,000
| +10% | +$39.7M | 4.44% | 6 |
|
|
2015
Q4 | $445M | Sell |
1,424,715
-18,600
| -1% | -$5.81M | 4.03% | 4 |
|
|
2015
Q3 | $392M | Sell |
1,443,315
-68,000
| -4% | -$18.5M | 3.96% | 5 |
|
|
2015
Q2 | $459M | Sell |
1,511,315
-66,872
| -4% | -$20.3M | 3.83% | 3 |
|
|
2015
Q1 | $470M | Buy |
1,578,187
+89,987
| +6% | +$26.8M | 4.01% | 4 |
|
|
2014
Q4 | $383M | Buy |
1,488,200
+52,000
| +4% | +$13.4M | 3.66% | 6 |
|
|
2014
Q3 | $347M | Buy |
1,436,200
+904,200
| +170% | +$218M | 3.62% | 6 |
|
|
2014
Q2 | $119M | Buy |
532,000
+37,000
| +7% | +$8.25M | 1.39% | 30 |
|
|
2014
Q1 | $102M | Sell |
495,000
-218,000
| -31% | -$44.9M | 1.25% | 26 |
|
|
2013
Q4 | $120M | Buy |
713,000
+237,900
| +50% | +$40M | 1.76% | 17 |
|
|
2013
Q3 | $68.4M | Sell |
475,100
-178,100
| -27% | -$25.6M | 1.22% | 26 |
|
|
2013
Q2 | $82.4M | Buy |
+653,200
| New | +$82.4M | 1.75% | 19 |
|